Dinner can either help or make it worse
avg body weight lost with Semaglutide (NEJM STEP 1 trial, 68 weeks) 2025% avg body weight lost with Tirzepatide (SURMOUNT-1, 7288 weeks) of semaglutide patients lost 5% of body weight (STEP 1 trial)of semaglutide patients lost 5% of body weight (STEP 1 trial) Week 14: Appetite reduction, smaller portions naturally Month 13: Steady fat loss begins, 12 lbs/week avg Month 36: Visible body composition change, reduced visceral fat 68 weeks: Average 14.9% total body weight reduction Ozempic for weight loss and Wegovy for weight loss produce comparable outcomes at equivalent doses
In more severe cases, patients can hear internal bodily sounds most people never notice from heartbeat and blood flow to neck creaking or even eye movement
Container type and integrity Most compounded tirzepatide arrives in glass vials with rubber stoppers sealed under aluminum crimps
Medication adjustment: If gastrointestinal side effects are contributing to back discomfort, discuss with your healthcare provider about slowing the titration schedule or temporarily holding at a lower dose until adaptation occurs
While the benefits of the weight loss associated with GLP-1 agonist therapy can no longer be denied, it remains the case that a significant amount of that weight loss comes from loss of muscle